The report on the Global Meningococcal Vaccines Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Major Drivers
- Expansion of routine immunization programs
- Increase in funding from the government of compulsory immunizations
|
Major Restraints
- Price wars for the vaccines from comparable drug makers
- Increasing financial austerity in the European nations
|
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments based on product type, formulation and indication. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as:
- GlaxoSmithKline PLC
- JN-International Medical Corporation
- Novartis International AG
- Sanofi SA
- Pfizer, Inc.
- Baxter International, Inc.
A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
SEGMENTATIONS IN THE REPORT:
By Product Type:
- Monovalent
- Bivalent
- Trivalent
- Tetravalent or Quadrivalent
By Formulation:
- Polysaccharide-based
- Conjugate-based
- Combination-based
By Indication:
- Pneumonia
- Meningitis
- Bacteremia
- Others (Arthritis, Conjunctivitis, Urethritis)
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East And Africa
The Global Meningococcal Vaccines Market has been exhibited in detail in the following chapters -
Chapter 1 Meningococcal Vaccines Market Preface
Chapter 2 Executive Summary
Chapter 3 Meningococcal Vaccines Industry Analysis
Chapter 4 Meningococcal Vaccines Market Value Chain Analysis
Chapter 5 Meningococcal Vaccines Market Analysis By Product Type
Chapter 6 Meningococcal Vaccines Market Analysis By Formulation
Chapter 7 Meningococcal Vaccines Market Analysis By Indication
Chapter 8 Meningococcal Vaccines Market Analysis By Geography
Chapter 9 Competitive Landscape Of Meningococcal Vaccines Companies
Chapter 10 Company Profiles Of Meningococcal Vaccines Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.